FINWIRES · TerminalLIVE
FINWIRES

Ares 从 Blackstone Energy Transition Partners 手中收购 Rover Pipeline 的股份

By

-- Ares Management (ARES) 周三表示,旗下基础设施机会策略基金已从黑石能源转型伙伴基金 (Blackstone Energy Transition Partners) 管理的基金手中收购了 Rover 输气管道 32.4% 的股份。 ARES 表示,Rover 输气管道由 Energy Transfer (ET) 运营,是一条天然气输送管道,为阿巴拉契亚盆地与北美各地终端市场提供至关重要的连接。

Price: $109.94, Change: $-3.08, Percent Change: -2.72%

Related Articles

Mining & Metals

Primaris REIT Reports Higher Profit, Total Rental Revenue for First Quarter; Full-year Outlook Maintained

Primaris Real Estate Investment Trust (PMZ-UN.TO) after trade Wednesday reported higher total rental revenue and profit for the first quarter and reaffirmed its 2026 outlook.The REIT earned $41.9 million, or $0.305 per unit, in the period, up from $31.2 million, or $0.257, a year ago. Corresponding FactSet figures were not available.Total rental revenue rose to $177.04 million from $150.2 million a year prior. FactSet expected sales of $180.8 million.Among other highlights, Primaris cited funds from operations per average diluted unit of $0.425 compared with $0.439 a year ago. FactSet projected FFO per share of $0.44."Our low leverage, low payout ratio model is a critical pillar to our strategy. We have significant liquidity with the full availability on our unsecured credit facility with no debt maturing in 2026, Chief Financial Officer Rags Davloor said."With strong liquidity, very low leverage, and a low payout ratio, we are well positioned to fund internal growth, enhance portfolio quality, and create long term value for our unitholders," Chief Executive Alex Avery added.The REIT said it is maintaining its full-year 2026 guidance.The REIT's units closed down $0.05 to $18.98 on the Toronto Stock Exchange.

$PMZ-UN.TO
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $1,347,066, According to a Recent SEC Filing

Anatol Kreitzer, Chief Discovery Officer, on April 27, 2026, sold 45,422 shares in Maplight Therapeutics (MPLT) for $1,347,066. Following the Form 4 filing with the SEC, Kreitzer has control over a total of 211,190 voting common shares of the company, with 211,190 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202123826000008/xslF345X05/form4-04292026_040429.xml

$MPLT
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $2,087,687, According to a Recent SEC Filing

Jonathan Gillis, Chief Administrative and Accounting Officer and Principal Accounting Officer, on April 27, 2026, sold 69,835 shares in Maplight Therapeutics (MPLT) for $2,087,687. Following the Form 4 filing with the SEC, Gillis has control over a total of 181,219 voting common shares of the company, with 181,219 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000170995426000008/xslF345X05/form4-04292026_040431.xml

$MPLT